Symmetry Partners’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
GCGM
Symmetry Partners's TDOC Position: Q2 2021 in Review
Symmetry Partners sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 2,537 shares — an estimated $461K sold.
Symmetry Partners first reported a position in TDOC in Q3 2020 and held it in 3 quarters. The position peaked at $510K in Q4 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.
- Symmetry Partners reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
- Symmetry Partners sold 2,537 Teladoc Health shares in Q2 2021, an estimated $461K.
- Symmetry Partners first reported a position in Teladoc Health in Q3 2020 and held it in 3 quarters.
- Symmetry Partners's Teladoc Health position peaked at $510K in Q4 2020.
- 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.
Based on Symmetry Partners's 13F filing for Q2 2021, filed 7 Jul 2021.